159 related articles for article (PubMed ID: 16034481)
1. The corticotropin-releasing factor-hypocretin connection: implications in stress response and addiction.
Pañeda C; Winsky-Sommerer R; Boutrel B; de Lecea L
Drug News Perspect; 2005 May; 18(4):250-5. PubMed ID: 16034481
[TBL] [Abstract][Full Text] [Related]
2. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response.
Winsky-Sommerer R; Yamanaka A; Diano S; Borok E; Roberts AJ; Sakurai T; Kilduff TS; Horvath TL; de Lecea L
J Neurosci; 2004 Dec; 24(50):11439-48. PubMed ID: 15601950
[TBL] [Abstract][Full Text] [Related]
3. Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry.
Winsky-Sommerer R; Boutrel B; de Lecea L
Mol Neurobiol; 2005 Dec; 32(3):285-94. PubMed ID: 16385142
[TBL] [Abstract][Full Text] [Related]
4. Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior.
Plaza-Zabala A; Martín-García E; de Lecea L; Maldonado R; Berrendero F
J Neurosci; 2010 Feb; 30(6):2300-10. PubMed ID: 20147556
[TBL] [Abstract][Full Text] [Related]
5. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.
Martin-Fardon R; Zorrilla EP; Ciccocioppo R; Weiss F
Brain Res; 2010 Feb; 1314():145-61. PubMed ID: 20026088
[TBL] [Abstract][Full Text] [Related]
6. Addiction and arousal: the hypocretin connection.
Boutrel B; de Lecea L
Physiol Behav; 2008 Mar; 93(4-5):947-51. PubMed ID: 18262574
[TBL] [Abstract][Full Text] [Related]
7. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems.
Sandi C; Cordero MI; Ugolini A; Varea E; Caberlotto L; Large CH
Eur J Neurosci; 2008 Nov; 28(9):1836-48. PubMed ID: 18973598
[TBL] [Abstract][Full Text] [Related]
8. Hypocretins and primary headaches: neurobiology and clinical implications.
Rainero I; De Martino P; Pinessi L
Expert Rev Neurother; 2008 Mar; 8(3):409-16. PubMed ID: 18345971
[TBL] [Abstract][Full Text] [Related]
9. Role of orexin/hypocretin and CRF in the formation of drug-dependent synaptic plasticity in the mesolimbic system.
Bonci A; Borgland S
Neuropharmacology; 2009; 56 Suppl 1():107-11. PubMed ID: 18694770
[TBL] [Abstract][Full Text] [Related]
10. Chronic psychosocial stress affects corticotropin-releasing factor in the paraventricular nucleus and central extended amygdala as well as urocortin 1 in the non-preganglionic Edinger-Westphal nucleus of the tree shrew.
Kozicz T; Bordewin LA; Czéh B; Fuchs E; Roubos EW
Psychoneuroendocrinology; 2008 Jul; 33(6):741-54. PubMed ID: 18394812
[TBL] [Abstract][Full Text] [Related]
11. Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety.
Shekhar A; Truitt W; Rainnie D; Sajdyk T
Stress; 2005 Dec; 8(4):209-19. PubMed ID: 16423710
[TBL] [Abstract][Full Text] [Related]
12. Exposure to neonatal separation stress alters exploratory behavior and corticotropin releasing factor expression in neurons in the amygdala and hippocampus.
Becker K; Abraham A; Kindler J; Helmeke C; Braun K
Dev Neurobiol; 2007 Apr; 67(5):617-29. PubMed ID: 17443812
[TBL] [Abstract][Full Text] [Related]
13. Input organization and plasticity of hypocretin neurons: possible clues to obesity's association with insomnia.
Horvath TL; Gao XB
Cell Metab; 2005 Apr; 1(4):279-86. PubMed ID: 16054072
[TBL] [Abstract][Full Text] [Related]
14. Role of corticotropin-releasing factor family peptides and receptors in stress-related psychiatric disorders.
Clark MS; Kaiyala KJ
Semin Clin Neuropsychiatry; 2003 Apr; 8(2):119-36. PubMed ID: 12728411
[TBL] [Abstract][Full Text] [Related]
15. Altered behavioural adaptation in mice with neural corticotrophin-releasing factor overexpression.
Kasahara M; Groenink L; Breuer M; Olivier B; Sarnyai Z
Genes Brain Behav; 2007 Oct; 6(7):598-607. PubMed ID: 17147700
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation.
Heinrichs SC; Koob GF
J Pharmacol Exp Ther; 2004 Nov; 311(2):427-40. PubMed ID: 15297468
[TBL] [Abstract][Full Text] [Related]
17. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
Borgland SL; Storm E; Bonci A
Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
[TBL] [Abstract][Full Text] [Related]
18. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat.
Sajdyk TJ; Fitz SD; Shekhar A
Stress; 2006 Mar; 9(1):21-8. PubMed ID: 16753930
[TBL] [Abstract][Full Text] [Related]
19. The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence.
Bruijnzeel AW; Gold MS
Brain Res Brain Res Rev; 2005 Nov; 49(3):505-28. PubMed ID: 16269317
[TBL] [Abstract][Full Text] [Related]
20. Activity-dependent release of adenosine inhibits the glutamatergic synaptic transmission and plasticity in the hypothalamic hypocretin/orexin neurons.
Xia J; Chen F; Ye J; Yan J; Wang H; Duan S; Hu Z
Neuroscience; 2009 Sep; 162(4):980-8. PubMed ID: 19465088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
